| EM | Endometriosis |
| ROS | Reactive oxygen species |
| OS | Oxidative stress |
| HOXA10 | Homeobox A10 |
| PGR-B | Progesterone receptor B |
| ESR1 (Era) | Estrogen receptor alpha |
| HDAC1/2 | Histone deacetylases 1 and 2 |
| H3K27me3 | Trimethylation of histone H3 lysine 27 |
| H3K9ac | Acetylation of histone H3 lysine 9 |
| H4K16ac | Acetylation of histone H4 lysine 16 |
| EZH2 | Enhancer of zeste homolog 2 |
| EMT | Epithelial–mesenchymal transition |
| DNMR(s) | Differentially methylated regions |
| miRNA | MicroRNA |
| SCFA | Short-chain fatty acid |
| LPS | Lipopolysaccharide |
| TLR | Toll-like receptor |
| COX-2 | Cyclooxygenase-2 |
| PGE2 | Prostaglandin E2 |
| VEGF | Vascular Endothelial Growth Factor |
| MMP | Matrix Metalloproteinase |
| TIMP | Tissue Inhibitor of Metalloproteinases |
| BPA | Bisphenol A |
| TCDD | 2,3,7,8-Tetrachlorodibenzo-p-dioxin |
| EDCs | Endocrine-disrupting chemicals |